Advertisement

Journal of Cancer Survivorship

, Volume 13, Issue 5, pp 713–729 | Cite as

Interventions to improve adherence to surveillance guidelines in survivors of childhood cancer: a systematic review

  • Veda Zabih
  • Alyssa Kahane
  • Natalya E. O’Neill
  • Noah Ivers
  • Paul C. NathanEmail author
Review

Abstract

Purpose

Many survivors of childhood cancer are at high risk of late effects of their cancer therapy, including cardiac toxicity and subsequent malignant neoplasms (SMN). Current North American guidelines recommend periodic surveillance for these late effects. We conducted a systematic review of the literature to estimate rates of adherence to recommended surveillance and summarize studies evaluating interventions intended to increase adherence.

Methods

We searched MEDLINE, Embase, Web of Science, and the Cumulative Index of Nursing and Allied Health Literature (CINAHL) for articles published between January 2000 and September 2018 that reported adherence to surveillance for cardiac toxicity and SMN (breast and colorectal cancer) and interventions implemented to improve completion of recommended testing. Risk of bias was assessed using relevant Cochrane checklists. Due to heterogeneity and overlapping study populations, we used narrative synthesis to summarize the findings. This review was registered in PROSPERO: CRD42018098878.

Results

Thirteen studies met our inclusion criteria for assessing adherence to surveillance, while five assessed interventions to improve rates of surveillance. No studies met criteria for low risk of bias. Completion of recommended surveillance was lowest for colorectal cancer screening (11.5–30.0%) followed by cardiomyopathy (22.3–48.1%) and breast cancer (37.0–56.5%). Factors such as patient-provider communication, engagement with the health care system, and receipt of information were consistently reported to be associated with higher rates of surveillance. Of five randomized controlled trials aimed at improving surveillance, only two significantly increase completion of recommended testing—one for echocardiography and one for mammography. Both involved telephone outreach to encourage and facilitate these tests.

Conclusion

The majority of childhood cancer survivors at high risk of cardiac toxicity or SMN do not receive evidence-based surveillance. There is paucity of rigorous studies evaluating interventions to increase surveillance in this population.

Implications for Cancer Survivors

Robust trials are needed to assess whether tailored interventions, designed based on unique characteristics and needs of each survivor population, could improve adherence.

Keywords

Childhood cancer Survivorship Screening Late effects of cancer treatment 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11764_2019_790_MOESM1_ESM.docx (84 kb)
ESM 1 (DOCX 84 kb)

References

  1. 1.
    Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128(17):1927–95.  https://doi.org/10.1161/CIR.0b013e3182a88099.CrossRefPubMedGoogle Scholar
  2. 2.
    Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27(14):2356–62.  https://doi.org/10.1200/jco.2008.21.1920.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MC. Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. Br J Cancer. 2004;91(11):1905–10.  https://doi.org/10.1038/sj.bjc.6602226.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21(23):4386–94.  https://doi.org/10.1200/jco.2003.11.059.CrossRefPubMedGoogle Scholar
  5. 5.
    Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Friedman DN, et al. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 2014;32(21):2217–23.  https://doi.org/10.1200/jco.2013.54.4601.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Teepen JC, Kok JL, van Leeuwen FE, Tissing WJE, Dolsma WV, van der Pal HJ, et al. Colorectal adenomas and cancers after childhood cancer treatment: a DCOG-LATER record linkage study. J Natl Cancer Inst. 2018;110(7):758–67.  https://doi.org/10.1093/jnci/djx266.CrossRefPubMedGoogle Scholar
  7. 7.
    Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 5.0. 2018, October. http://www.survivorshipguidelines.org/. Accessed 22 Mar 2019.
  8. 8.
    Gan HW, Spoudeas HA. Long-term follow-up of survivors of childhood cancer (SIGN clinical guideline 132). Arch Dis Child Educ Pract Ed. 2014;99(4):138–43.  https://doi.org/10.1136/archdischild-2013-305452.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Institute NC. Late effects of treatment for childhood cancer (PDQ®)–Health Professional Version. https://www.cancer.gov/types/childhood-cancers/late-effects-hp-pdq. Accessed 01 December 2018.
  10. 10.
    Sieswerda E, Postma A, van Dalen EC, van der Pal HJ, Tissing WJ, Rammeloo LA, et al. The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol. 2012;23(8):2191–8.  https://doi.org/10.1093/annonc/mdr595.CrossRefPubMedGoogle Scholar
  11. 11.
    Skinner R, Wallace WHB, Levitt GA, eds. Therapy based long term follow up: practice statement. UK Children's Cancer Study Group. Second Edition April 2005. https://www.uhb.nhs.uk/Downloads/pdf/CancerPbTherapyBasedLongTermFollowUp.pdf. Accessed 10 Feb 2019.
  12. 12.
    Von der Weid N. Standardized assessment of late effects in long-term survivors of childhood cancer in Switzerland: results of a Swiss Pediatric Oncology Group (SPOG) pilot study. Int J Pediatr Hematol Oncol. 1996;3:483–90.Google Scholar
  13. 13.
    Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, et al. Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(11):1362–89.  https://doi.org/10.6004/jnccn.2018.0083.CrossRefGoogle Scholar
  14. 14.
    Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, et al. Hodgkin lymphoma version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(5):608–38.CrossRefGoogle Scholar
  15. 15.
    Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group long-term follow-up guidelines from the Children’s Oncology Group late effects committee and nursing discipline. J Clin Oncol. 2004;22(24):4979–90.  https://doi.org/10.1200/jco.2004.11.032.CrossRefPubMedGoogle Scholar
  16. 16.
    Cox CL, Oeffinger KC, Montgomery M, Hudson MM, Mertens AC, Whitton J, et al. Determinants of mammography screening participation in adult childhood cancer survivors: results from the Childhood Cancer Survivor Study. Oncol Nurs Forum. 2009;36(3):335–44.  https://doi.org/10.1188/09.ONF.335-344.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Daniel CL, Kohler CL, Stratton KL, Oeffinger KC, Leisenring WM, Waterbor JW, et al. Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study. Cancer. 2015;121(11):1856–63.  https://doi.org/10.1002/cncr.29265.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hudson MM, Andersen MR, Santucci AK, Robison LL, Cox CL. Increasing cardiomyopathy screening in childhood cancer survivors: a cost analysis of advanced practice nurse phone counseling. Oncol Nurs Forum. 2016;43(6):E242–E50.  https://doi.org/10.1188/16.ONF.E242-E250.CrossRefPubMedGoogle Scholar
  19. 19.
    Kadan-Lottick NS, Ross WL, Mitchell H-R, Rotatori J, Gross CP, Ma X. Randomized trial of the impact of empowering childhood cancer survivors with survivorship care plans. J Natl Cancer Inst. 2018;110:1352–9.  https://doi.org/10.1093/jnci/djy057.CrossRefPubMedGoogle Scholar
  20. 20.
    Cochrane Methods. Cochrane Database of Systematic Reviews, 10 (Suppl 1) [database on the Internet]. Cochrane Library. 2016. Available from: https://www.nccmt.ca/knowledge-repositories/search/280. Accessed 10 Feb 2019.
  21. 21.
    Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.  https://doi.org/10.1136/bmj.i4919.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38(4):229–39.CrossRefGoogle Scholar
  23. 23.
    Baxstrom K, Peterson BA, Lee C, Vogel RI, Blaes AH. A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma. Support Care Cancer. 2018;26(7):2361–8.  https://doi.org/10.1007/s00520-018-4072-x.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Oeffinger KC, Ford JS, Moskowitz CS, Diller LR, Hudson MM, Chou JF, et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA. 2009;301(4):404–14.  https://doi.org/10.1001/jama.2008.1039.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Rosenberg SM, Moskowitz CS, Ford JS, Henderson TO, Frazier AL, Diller LR, et al. Health care utilization, lifestyle, and emotional factors and mammography practices in the childhood cancer survivor study. Cancer Epidemiol Biomark Prev. 2015;24(11):1699–706.  https://doi.org/10.1158/1055-9965.EPI-14-1377.CrossRefGoogle Scholar
  26. 26.
    Nathan PC, Greenberg ML, Ness KK, Hudson MM, Mertens AC, Mahoney MC, et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26(27):4401–9.  https://doi.org/10.1200/JCO.2008.16.9607.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Nathan PC, Ness KK, Mahoney MC, Li Z, Hudson MM, Ford JS, et al. Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study.[Summary for patients in Ann Intern Med. 2010 Oct 5;153(7):I42; PMID: 20921538]. Ann Intern Med. 2010;153(7):442–51.  https://doi.org/10.7326/0003-4819-153-7-201010050-00007.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Steele JR, Wall M, Salkowski N, Mitby P, Kawashima T, Yeazel MW, et al. Predictors of risk-based medical follow-up: a report from the childhood cancer survivor study. J Cancer Surviv-Res Pract. 2013;7(3):379–91.  https://doi.org/10.1007/s11764-013-0280-z.CrossRefGoogle Scholar
  29. 29.
    Marr KC, Agha M, Sutradhar R, Pole JD, Hodgson D, Guttmann A, et al. Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer. J Cancer Surviv. 2017;11(5):614–23.  https://doi.org/10.1007/s11764-017-0634-z.CrossRefPubMedGoogle Scholar
  30. 30.
    Reppucci ML, Schleien CL, Fish JD. Looking for trouble: adherence to late-effects surveillance among childhood cancer survivors. Pediatr Blood Cancer. 2017;64(2):353–7.  https://doi.org/10.1002/pbc.26205.CrossRefPubMedGoogle Scholar
  31. 31.
    Madden NA, Deng C, Fitch T, Effinger KE, Zhang C, Goyal S, et al. Adherence to Children’s Oncology Group (COG) long-term follow-up guidelines for echocardiogram screening in young adult survivors of childhood cancer. J Clin Oncol. 2018;36(15_suppl):e22513-e.  https://doi.org/10.1200/JCO.2018.36.15_suppl.e22513.CrossRefGoogle Scholar
  32. 32.
    Cox CL, Hudson MM, Mertens A, Oeffinger K, Whitton J, Montgomery M, et al. Medical screening participation in the Childhood Cancer Survivor Study. Arch Intern Med. 2009;169(5):454–62.  https://doi.org/10.1001/archinternmed.2008.588.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Oeffinger KC, Ford J, Moskowitz CS, Chou JF, Henderson TO, Hudson MM, et al. The EMPOWER study: promoting breast cancer screening—a randomized controlled trial (RCT) in the Childhood Cancer Survivor Study (CCSS). J Clin Oncol. 2016;34(15_suppl):10506.  https://doi.org/10.1200/JCO.2016.34.15_suppl.10506.CrossRefGoogle Scholar
  34. 34.
    Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, et al. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2011;56(5):818–24.  https://doi.org/10.1002/pbc.22696.CrossRefPubMedGoogle Scholar
  35. 35.
    Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, et al. Childhood cancer survivors’ knowledge about their past diagnosis and treatment: Childhood Cancer Survivor Study. Jama. 2002;287(14):1832–9.CrossRefGoogle Scholar
  36. 36.
    Mertens AC, Cotter KL, Foster BM, Zebrack BJ, Hudson MM, Eshelman D, et al. Improving health care for adult survivors of childhood cancer: recommendations from a delphi panel of health policy experts. Health Policy (Amsterdam, Netherlands). 2004;69(2):169–78.  https://doi.org/10.1016/j.healthpol.2003.12.008.CrossRefGoogle Scholar
  37. 37.
    Zebrack BJ, Eshelman DA, Hudson MM, Mertens AC, Cotter KL, Foster BM, et al. Health care for childhood cancer survivors: insights and perspectives from a Delphi panel of young adult survivors of childhood cancer. Cancer. 2004;100(4):843–50.  https://doi.org/10.1002/cncr.20033.CrossRefPubMedGoogle Scholar
  38. 38.
    Sheen V, Tucker MA, Abramson DH, Seddon JM, Kleinerman RA. Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer. 2008;113(2):434–41.  https://doi.org/10.1002/cncr.23564.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Smith SM, Ford JS, Rakowski W, Moskowitz CS, Diller L, Hudson MM, et al. Inconsistent mammography perceptions and practices among women at risk of breast cancer following a pediatric malignancy: a report from the Childhood Cancer Survivor Study. Cancer Causes Control. 2010;21(10):1585–95.  https://doi.org/10.1007/s10552-010-9587-5.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Johnson R, Horne B, Feltbower RG, Butler GE, Glaser AW. Hospital attendance patterns in long term survivors of cancer. Arch Dis Child. 2004;89(4):374–7.CrossRefGoogle Scholar
  41. 41.
    Rebholz CE, von der Weid NX, Michel G, Niggli FK, Kuehni CE. Follow-up care amongst long-term childhood cancer survivors: a report from the Swiss Childhood Cancer Survivor Study. Eur J Cancer (Oxford, England : 1990). 2011;47(2):221–9.  https://doi.org/10.1016/j.ejca.2010.09.017.CrossRefGoogle Scholar
  42. 42.
    Vetsch J, Rueegg CS, Mader L, Bergstraesser E, Rischewski J, Kuehni CE, et al. Follow-up care of young childhood cancer survivors: attendance and parental involvement. Support Care Cancer. 2016;24(7):3127–38.  https://doi.org/10.1007/s00520-016-3121-6.CrossRefPubMedGoogle Scholar
  43. 43.
    Nathan PC, Agha M, Pole JD, Hodgson D, Guttmann A, Sutradhar R, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10(4):611–8.  https://doi.org/10.1007/s11764-016-0522-y.CrossRefPubMedGoogle Scholar
  44. 44.
    Devine KA, Viola A, Capucilli P, Sahler OJ, Andolina JR. Factors associated with noncompliance with long-term follow-up care among pediatric cancer survivors. J Pediatr Hematol Oncol. 2017;39(3):167–73.  https://doi.org/10.1097/mph.0000000000000744.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Klosky JL, Cash DK, Buscemi J, Lensing S, Garces-Webb DM, Zhao W, et al. Factors influencing long-term follow-up clinic attendance among survivors of childhood cancer. J Cancer Surviv. 2008;2(4):225–32.  https://doi.org/10.1007/s11764-008-0063-0.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Barakat LP, Schwartz LA, Szabo MM, Hussey HM, Bunin GR. Factors that contribute to post-treatment follow-up care for survivors of childhood cancer. J Cancer Surviv. 2012;6(2):155–62.  https://doi.org/10.1007/s11764-011-0206-6.CrossRefPubMedGoogle Scholar
  47. 47.
    Nathan PC, Daugherty CK, Wroblewski KE, Kigin ML, Stewart TV, Hlubocky FJ, et al. Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2013;7(3):275–82.  https://doi.org/10.1007/s11764-013-0271-0.CrossRefPubMedGoogle Scholar
  48. 48.
    Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CK. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. J Clin Oncol 2010;28(5):878–883. doi: https://doi.org/10.1200/jco.2009.25.6107.
  49. 49.
    Suh E, Daugherty CK, Wroblewski K, Lee H, Kigin ML, Rasinski KA, et al. General internists’ preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014;160(1):11–7.  https://doi.org/10.7326/m13-1941.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Henderson TO, Friedman DL, Meadows AT. Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics. 2010;126(1):129–36.  https://doi.org/10.1542/peds.2009-2802.CrossRefPubMedGoogle Scholar
  51. 51.
    Blaauwbroek R, Barf HA, Groenier KH, Kremer LC, van der Meer K, Tissing WJE, et al. Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan. J Cancer Surviv. 2012;6(2):163–71.  https://doi.org/10.1007/s11764-011-0207-5.CrossRefPubMedGoogle Scholar
  52. 52.
    Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27(14):2405–14.  https://doi.org/10.1200/jco.2008.21.1516.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Bhatia S. Cancer survivorship--pediatric issues. Hematology Am Soc Hematol Educ Program. 2005;2005:507–15.  https://doi.org/10.1182/asheducation-2005.1.507.CrossRefGoogle Scholar
  54. 54.
    Edgar AB, Borthwick S, Duffin K, Marciniak-Stepak P, Wallace WH. Survivors of childhood cancer lost to follow-up can be re-engaged into active long-term follow-up by a postal health questionnaire intervention. Eur J Cancer (Oxford, England : 1990). 2012;48(7):1066–73.  https://doi.org/10.1016/j.ejca.2011.06.009.CrossRefGoogle Scholar
  55. 55.
    Jabson JM. Treatment summaries, follow-up care instructions, and patient navigation: could they be combined to improve cancer survivor’s receipt of follow-up care? J Cancer Surviv. 2015;9(4):692–8.  https://doi.org/10.1007/s11764-015-0444-0.CrossRefPubMedGoogle Scholar
  56. 56.
    Landier W, Bhatia S. Cancer survivorship: a pediatric perspective. Oncologist. 2008;13(11):1181–92.  https://doi.org/10.1634/theoncologist.2008-0104.CrossRefPubMedGoogle Scholar
  57. 57.
    Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med. 2004;2(1):61–70.CrossRefGoogle Scholar
  58. 58.
    Skinner R, Wallace WHB, Levitt G. Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how? Arch Dis Child. 2007;92(3):257–60.  https://doi.org/10.1136/adc.2006.095513.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol. 2010;28(32):4810–8.  https://doi.org/10.1200/jco.2009.23.4278.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol. 2006;24(32):5117–24.  https://doi.org/10.1200/jco.2006.07.0474.CrossRefPubMedGoogle Scholar
  61. 61.
    Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FAR, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Jama. 2016;315(23):2564–75.  https://doi.org/10.1001/jama.2016.5989.CrossRefPubMedGoogle Scholar
  62. 62.
    Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26, w-236.  https://doi.org/10.7326/0003-4819-151-10-200911170-00008.
  63. 63.
    Basch CE, Wolf RL, Brouse CH, Shmukler C, Neugut A, DeCarlo LT, et al. Telephone outreach to increase colorectal cancer screening in an urban minority population. Am J Public Health. 2006;96(12):2246–53.  https://doi.org/10.2105/AJPH.2005.067223.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Carney PA, Harwood BG, Greene MA, Goodrich ME. Impact of a telephone counseling intervention on transitions in stage of change and adherence to interval mammography screening (United States). Cancer Causes Control. 2005;16(7):799–807.  https://doi.org/10.1007/s10552-005-2612-4.CrossRefPubMedGoogle Scholar
  65. 65.
    Cha JM, Lee JI, Joo KR, Shin HP, Park JJ. Telephone reminder call in addition to mailing notification improved the acceptance rate of colonoscopy in patients with a positive fecal immunochemical test. Dig Dis Sci. 2011;56(11):3137–42.  https://doi.org/10.1007/s10620-011-1720-0.CrossRefPubMedGoogle Scholar
  66. 66.
    Chambers JA, Gracie K, Millar R, Cavanagh J, Archibald D, Cook A, et al. A pilot randomized controlled trial of telephone intervention to increase breast cancer screening uptake in socially deprived areas in Scotland (TELBRECS). J Med Screen. 2016;23(3):141–9.  https://doi.org/10.1177/0969141315608212.CrossRefPubMedGoogle Scholar
  67. 67.
    Champion V, Skinner CS, Hui S, Monahan P, Juliar B, Daggy J, et al. The effect of telephone versus print tailoring for mammography adherence. Patient Educ Couns. 2007;65(3):416–23.  https://doi.org/10.1016/j.pec.2006.09.014.CrossRefPubMedGoogle Scholar
  68. 68.
    Champion VL, Rawl SM, Bourff SA, Champion KM, Smith LG, Buchanan AH, et al. Randomized trial of DVD, telephone, and usual care for increasing mammography adherence. J Health Psychol. 2016;21(6):916–26.  https://doi.org/10.1177/1359105314542817.CrossRefPubMedGoogle Scholar
  69. 69.
    Champion VL, Skinner CS, Foster JL. The effects of standard care counseling or telephone/in-person counseling on beliefs, knowledge, and behavior related to mammography screening. Oncol Nurs Forum. 2000;27(10):1565–71.PubMedGoogle Scholar
  70. 70.
    Cohen-Cline H, Wernli KJ, Bradford SC, Boles-Hall M, Grossman DC. Use of interactive voice response to improve colorectal cancer screening. Med Care. 2014;52(6):496–9.  https://doi.org/10.1097/MLR.0000000000000116.CrossRefPubMedGoogle Scholar
  71. 71.
    Costanza ME, Stoddard AM, Luckmann R, White MJ, Spitz Avrunin J, Clemow L. Promoting mammography. Results of a randomized trial of telephone counseling and a medical practice intervention. Am J Prev Med. 2000;19(1):39–46.  https://doi.org/10.1016/S0749-3797%2800%2900150-1.CrossRefPubMedGoogle Scholar
  72. 72.
    Denis B, Broc G, Sauleau EA, Gendre I, Gana K, Perrin P. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: a randomized controlled trial. Rev Epidemiol Sante Publique. 2017;65(1):17–28.  https://doi.org/10.1016/j.respe.2016.06.336.CrossRefPubMedGoogle Scholar
  73. 73.
    Dietrich AJ, Tobin JN, Cassells A, Robinson CM, Greene MA, Sox CH, et al. Telephone care management to improve cancer screening among low-income women - a randomized, controlled trial. Ann Intern Med. 2006;144(8):563–71.  https://doi.org/10.7326/0003-4819-144-8-200604180-00006.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Dietrich AJ, Tobin JN, Robinson CM, Cassells A, Greene MA, Dunn VH, et al. Telephone outreach to increase colon cancer screening in Medicaid managed care organizations: a randomized controlled trial. Ann Fam Med. 2013;11(4):335–43.  https://doi.org/10.1370/afm.1469.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Ford ME, Havstad S, Vernon SW, Davis SD, Kroll D, Lamerato L, et al. Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial. Gerontologist. 2006;46(4):545–50.CrossRefGoogle Scholar
  76. 76.
    Hegenscheid K, Hoffmann W, Fochler S, Domin M, Weiss S, Hartmann B, et al. Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med. 2011;41(4):421–7.  https://doi.org/10.1016/j.amepre.2011.06.040.CrossRefPubMedGoogle Scholar
  77. 77.
    Kempe KL, Shetterly SM, France EK, Levin TR. Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012;18(7):370–8.PubMedGoogle Scholar
  78. 78.
    Mosen DM, Feldstein AC, Perrin N, Rosales AG, Smith DH, Liles EG, et al. Automated telephone calls improved completion of fecal occult blood testing. Med Care. 2010;48(7):604–10.  https://doi.org/10.1097/MLR.0b013e3181dbdce7.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Simon SR, Zhang F, Soumerai SB, Ensroth A, Bernstein L, Fletcher RH, et al. Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2010;170(3):264–70.  https://doi.org/10.1001/archinternmed.2009.522.CrossRefPubMedGoogle Scholar
  80. 80.
    Kerrison RS, Shukla H, Cunningham D, Oyebode O, Friedman E. Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population. Br J Cancer. 2015;112:1005–10.  https://doi.org/10.1038/bjc.2015.36.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Jean-Jacques M, Kaleba EO, Gatta JL, Gracia G, Ryan ER, Choucair BN. Program to improve colorectal cancer screening in a low-income, racially diverse population: a randomized controlled trial. Ann Fam Med. 2012;10(5):412–7.  https://doi.org/10.1370/afm.1381.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Jensen JD, King AJ, Carcioppolo N, Krakow M, Samadder NJ, Morgan S. Comparing tailored and narrative worksite interventions at increasing colonoscopy adherence in adults 50–75: a randomized controlled trial. Soc Sci Med. 2014;104:31–40.  https://doi.org/10.1016/j.socscimed.2013.12.003.CrossRefPubMedGoogle Scholar
  83. 83.
    Kerrison RS, McGregor LM, Marshall S, Isitt J, Counsell N, Rees CJ, et al. Improving uptake of flexible sigmoidoscopy screening: a randomized trial of nonparticipant reminders in the English screening programme. Endoscopy. 2017;49(1):35–43.  https://doi.org/10.1055/s-0042-118452.CrossRefPubMedGoogle Scholar
  84. 84.
    Bowen DJ, Robbins R, Bush N, Meischke H, Ludwig A, Wooldridge J. Effects of a web-based intervention on women’s breast health behaviors. Transl Behav Med. 2017;7(2):309–19.  https://doi.org/10.1007/s13142-016-0439-z.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Enard KR, Nevarez L, Hernandez M, Hovick SR, Moguel MR, Hajek RA, et al. Patient navigation to increase colorectal cancer screening among Latino Medicare enrollees: a randomized controlled trial. Cancer Causes Control. 2015;26(9):1351–9.  https://doi.org/10.1007/s10552-015-0620-6.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Ha TC, Yong SK, Yeoh K-W, Kamberakis K, Yeo RMC, Koh GC-H. The effect of test kit provision, and individual and family education on the uptake rates of fecal occult blood test in an Asian population: a randomized controlled trial. Cancer Causes Control. 2014;25(11):1473–88.  https://doi.org/10.1007/s10552-014-0449-4.CrossRefPubMedGoogle Scholar
  87. 87.
    Jandorf L, Braschi C, Ernstoff E, Wong CR, Thelemaque L, Winkel G, et al. Culturally targeted patient navigation for increasing African Americans’ adherence to screening colonoscopy: a randomized clinical trial. Cancer Epidemiol Biomark Prev. 2013;22(9):1577–87.  https://doi.org/10.1158/1055-9965.EPI-12-1275.CrossRefGoogle Scholar
  88. 88.
    Maxwell AE, Bastani R, Danao LL, Antonio C, Garcia GM, Crespi CM. Results of a community-based randomized trial to increase colorectal cancer screening among Filipino Americans. Am J Public Health. 2010;100(11):2228–34.  https://doi.org/10.2105/AJPH.2009.176230.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000;133(10):761.CrossRefGoogle Scholar
  90. 90.
    Sadler GR, Beerman PR, Lee K, Hung J, Nguyen H, Cho J, et al. Promoting breast cancer screening among Asian American women: the Asian grocery store-based cancer education program. J Cancer Educ. 2012;27(4):612–7.CrossRefGoogle Scholar
  91. 91.
    Wilson CJ, Flight IH, Turnbull D, Gregory T, Cole SR, Young GP, et al. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation. BMC Med Inform Decis Mak. 2015;15:25.  https://doi.org/10.1186/s12911-015-0147-5.CrossRefPubMedPubMedCentralGoogle Scholar
  92. 92.
    Allgood PC, Maroni R, Hudson S, Offman J, Turnbull AE, Peacock L, et al. Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial. Lancet Oncol. 2017;18(7):972–80.  https://doi.org/10.1016/S1470-2045(17)30340-6.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Ahmed NU, Haber G, Semenya KA, Hargreaves MK. Randomized controlled trial of mammography intervention in insured very low-income women. Cancer Epidemiol Biomark Prev. 2010;19(7):1790–8.  https://doi.org/10.1158/1055-9965.EPI-10-0141.CrossRefGoogle Scholar
  94. 94.
    Baker D, Brown T, Goldman S, Liss D, Kollar S, Balsley K, et al. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers. Cancer Causes Control. 2015;26(11):1685–90.  https://doi.org/10.1007/s10552-015-0650-0.CrossRefPubMedGoogle Scholar
  95. 95.
    Baker DW, Brown T, Buchanan DR, Weil J, Balsley K, Ranalli L, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235–41.  https://doi.org/10.1001/jamainternmed.2014.2352.CrossRefPubMedGoogle Scholar
  96. 96.
    Fortuna RJ, Idris A, Winters P, Humiston SG, Scofield S, Hendren S, et al. Get screened: a randomized trial of the incremental benefits of reminders, recall, and outreach on cancer screening. J Gen Intern Med. 2013;29:1–8.  https://doi.org/10.1007/s11606-013-2586-y.CrossRefGoogle Scholar
  97. 97.
    Giordano L, Stefanini V, Senore C, Frigerio A, Castagno R, Marra V, et al. The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years. Eur J Pub Health. 2012;22(3):413–8.CrossRefGoogle Scholar
  98. 98.
    Green BB, Anderson ML, Cook AJ, Chubak J, Fuller S, Meenan RT, et al. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer (0008543X). 2017;123(22):4472–80.  https://doi.org/10.1002/cncr.30908.CrossRefGoogle Scholar
  99. 99.
    Hendren S, Winters P, Humiston S, Idris A, Li SXL, Ford P, et al. Randomized, controlled trial of a multimodal intervention to improve cancer screening rates in a safety-net primary care practice. J Gen Intern Med. 2014;29(1):41–9.  https://doi.org/10.1007/s11606-013-2506-1.CrossRefPubMedGoogle Scholar
  100. 100.
    LoConte NK, Deming DA. Mailed invitations for colorectal screening are effective in increasing screening participation in uninsured adults with faecal immunochemical testing: The preferred screening modality. Evid Based Med. 2014;19(4):145.  https://doi.org/10.1136/eb-2014-101772.CrossRefPubMedGoogle Scholar
  101. 101.
    Slater JS, Henly GA, Ha CN, Malone ME, Nyman JA, Diaz S, et al. Effect of direct mail as a population-based strategy to increase mammography use among low-income underinsured women ages 40 to 64 years. Cancer Epidemiol Biomark Prev. 2005;14(10):2346–52.  https://doi.org/10.1158/1055-9965.EPI-05-0034.CrossRefGoogle Scholar
  102. 102.
    Myers RE, Bittner-Fagan H, Daskalakis C, Sifri R, Vernon SW, Cocroft J, et al. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2013;22(1):109–17.  https://doi.org/10.1158/1055-9965.EPI-12-0701.CrossRefGoogle Scholar
  103. 103.
    Cox CL. Online exclusive: a model of health behavior to guide studies of childhood cancer survivors. Oncol Nurs Forum. 2003;30(5):E92–9.  https://doi.org/10.1188/03.Onf.E92-e99.CrossRefPubMedGoogle Scholar
  104. 104.
    Wong FL, Bhatia S, Landier W, Francisco L, Leisenring W, Hudson MM, et al. Cost-effectiveness of the children’s oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med. 2014;160(10):672–83.  https://doi.org/10.7326/m13-2498.CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA. A “SMART” design for building individualized treatment sequences. Annu Rev Clin Psychol. 2012;8:21–48.  https://doi.org/10.1146/annurev-clinpsy-032511-143152.CrossRefPubMedGoogle Scholar
  106. 106.
    Haupt R, Essiaf S, Dellacasa C, Ronckers CM, Caruso S, Sugden E, et al. The ‘Survivorship Passport’ for childhood cancer survivors. Eur J Cancer (Oxford, England : 1990). 2018;102:69–81.  https://doi.org/10.1016/j.ejca.2018.07.006.CrossRefGoogle Scholar
  107. 107.
    Williamson R, Meacham L, Cherven B, Hassen-Schilling L, Edwards P, Palgon M, et al. Predictors of successful use of a web-based healthcare document storage and sharing system for pediatric cancer survivors: Cancer SurvivorLink. J Cancer Surviv. 2014;8(3):355–63.  https://doi.org/10.1007/s11764-014-0346-6.CrossRefPubMedGoogle Scholar
  108. 108.
    Casillas J, Goyal A, Bryman J, Alquaddoomi F, Ganz PA, Lidington E, et al. Development of a text messaging system to improve receipt of survivorship care in adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2017;11(4):505–16.  https://doi.org/10.1007/s11764-017-0609-0.CrossRefPubMedPubMedCentralGoogle Scholar
  109. 109.
    Psihogios AM, Li Y, Butler E, Hamilton J, Daniel LC, Barakat LP, et al. Text message responsivity in a 2-way short message service pilot intervention with adolescent and young adult survivors of cancer. JMIR mHealth uHealth. 2019;7(4):e12547.  https://doi.org/10.2196/12547.CrossRefPubMedPubMedCentralGoogle Scholar
  110. 110.
    Assessing the acceptability of the use of a mobile health app among young adult female survivors of childhood cancer. https://ClinicalTrials.gov/show/NCT03242200. Accessed 15 Mar 2019.
  111. 111.
    TICOP Mobile app and E-platform: providing information and support for parents caring for their child cancer survivor. https://ClinicalTrials.gov/show/NCT03945032. Accessed 15 Mar 2019.
  112. 112.
    Promoting breast cancer screening in women who survived childhood cancer. https://ClinicalTrials.gov/show/NCT03435380. Accessed 15 Mar 2019.

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Veda Zabih
    • 1
  • Alyssa Kahane
    • 2
  • Natalya E. O’Neill
    • 3
  • Noah Ivers
    • 4
    • 5
  • Paul C. Nathan
    • 1
    • 5
    Email author
  1. 1.Division of Hematology/OncologyThe Hospital for Sick ChildrenTorontoCanada
  2. 2.University of OttawaOttawaCanada
  3. 3.Faculty of MedicineUniversity of TorontoTorontoCanada
  4. 4.Department of Family and Community MedicineUniversity of TorontoTorontoCanada
  5. 5.Institute of Health Policy Management and Evaluation, Dalla Lana School of Public HealthUniversity of TorontoTorontoCanada

Personalised recommendations